Clinical Trial Update: Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating low-dose corticosteroids for relapse of nephrotic syndrome, sponsored by Rabin Medical Center; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Corticosteroids (low-dose) (corticosteroids)

Snippet

Sponsor: Rabin Medical Center | Conditions: Glomerular Disease | Phase 4 | Status: UNKNOWN